English
This article is from International Journal of Preventive Medicine , volume 5 . Abstract Chronic kidney disease is one of the most common complication of systemic lupus erythematosus, which if untreated can lead to the end-stage renal disease (ESRD). Early diagnosis and adequate treatment of lupus nephritis (LN) is critical to prevent the chronic kidney disease incidence and to reduce the development of ESRD. The treatment of LN has changed significantly over the past decade. In patients with active proliferative LN (Classes III and IV) intravenous methylprednisolone 1 g/m2/day for 1-3 days then prednisone 0.5-1.0 mg/kg/day, tapered to <0.5 mg/kg/day after 10-12 weeks of treatment plus mycophenolate mofetile (MMF) 1.2 g/m2/day for 6 months followed by maintenance lower doses of MMF 1-2 g/day or azathioprine (AZA) 2 mg/kg/day for 3 years have proven to be efficacy and less toxic than cyclophosphamide (CYC) therapy. Patients with membranous LN (Class V) plus diffuse or local proliferative LN (Class III and Class IV) should receive either the standard 6 monthly pulses of CYC (0.5-1 g/m2/month) then every 3rd month or to a shorter treatment course consisting of 0.5 g/m2 IV CYC every 2 w
Sign in with your free account to read, download EPUBs or listen.
Ebook · A Treatment Algorithm for Children with Lupus Nephritis to Prevent Developing Renal Failure. · Hajizadeh, Nilofar, Laijani, Faezeh Javadi, Moghtaderi, Mastaneh, Ataei, Neamatollah, Assadi, Farahnak · Internet Archive